Nicolas Lanthier

About Nicolas Lanthier

Nicolas Lanthier, With an exceptional h-index of 28 and a recent h-index of 25 (since 2020), a distinguished researcher at Université Catholique de Louvain, specializes in the field of Hepatology, Gastroenterology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance

Jaundice with severe leucocytosis

A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis

Transplantation, MICI et stéatose hépatique: quelques nouveautés en 2023

Transplantation, chronic inflammatory bowel disease, and hepatic steatosis: highlights in 2023

Nutrition et maladie stéatosique du foie: pas d’évidence d’un impact de la consommation d’aliments ultra-transformés sur la sévérité de l’atteinte hépatique

Création de crackers enrichis en acides gras polyinsaturés avec des bénéfices pour les paramètres métaboliques: un essai contrôlé randomisé en double aveugle chez des sujets en …

A Randomized Controlled Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

Nicolas Lanthier Information

University

Position

___

Citations(all)

3527

Citations(since 2020)

2426

Cited By

1647

hIndex(all)

28

hIndex(since 2020)

25

i10Index(all)

55

i10Index(since 2020)

49

Email

University Profile Page

Google Scholar

Nicolas Lanthier Skills & Research Interests

Hepatology

Gastroenterology

Top articles of Nicolas Lanthier

Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance

JCI insight

2024/4/8

Jaundice with severe leucocytosis

Journal of Hepatology

2024/3/1

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis

New England Journal of Medicine

2024/2/8

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Transplantation, MICI et stéatose hépatique: quelques nouveautés en 2023

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Transplantation, chronic inflammatory bowel disease, and hepatic steatosis: highlights in 2023

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Peter Stärkel
Peter Stärkel

H-Index: 36

Nutrition et maladie stéatosique du foie: pas d’évidence d’un impact de la consommation d’aliments ultra-transformés sur la sévérité de l’atteinte hépatique

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Création de crackers enrichis en acides gras polyinsaturés avec des bénéfices pour les paramètres métaboliques: un essai contrôlé randomisé en double aveugle chez des sujets en …

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

A Randomized Controlled Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

New England Journal of Medicine

2024

Liver elasticity evolution in metabolic dysfunction-associated steatotic liver disease patients: a real-life prospective study

Acta Gastro-Enterologica Belgica

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Creation of snacks enriched with polyunsaturated fatty acids and benefits for metabolic parameters: a double-blind randomised controlled trial in overweight subjects

Acta Gastro-Enterologica Belgica

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Impact of peroxisome proliferator-activated receptor agonists on myosteatosis in the context of metabolic dysfunction-associated steatotic liver disease

Obesity Reviews

2007/7/1

Frailty in MASLD patients is associated with the presence of diabetes and the degree of liver fibrosis

Acta Gastro-Enterologica Belgica

2024

Thierry Lejeune
Thierry Lejeune

H-Index: 24

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Exploring the impact of dietary patterns and ultra-processed food consumption on the severity of biopsy-proven steatotic liver disease

Acta Gastro-Enterologica Belgica

2024

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease

2023/11/14

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients

Journal of clinical and translational hepatology

2023/11/11

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Alcohol Consumption and Skeletal Muscle: What We Know and What We Would Like to Know

2023/9

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Fibrosis and steatosis of the liver graft: are non-invasive tests useful? A short review.

2023/8/9

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia

Journal of cachexia, sarcopenia and muscle

2023/6

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

Andrea Bonetto
Andrea Bonetto

H-Index: 23

Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues

Journal of hepatology

2023/5/1

Nicolas Lanthier
Nicolas Lanthier

H-Index: 16

See List of Professors in Nicolas Lanthier University(Université Catholique de Louvain)